CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax.
Mol Pharmacol
; 96(4): 419-429, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31467029
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Pyrazoles
/
Sulfonamides
/
Protein Kinase Inhibitors
/
Cyclin-Dependent Kinase 5
/
Myeloid Cell Leukemia Sequence 1 Protein
/
Aniline Compounds
Limits:
Humans
Language:
En
Journal:
Mol Pharmacol
Year:
2019
Document type:
Article
Country of publication:
United States